Skip to main content
Top
Published in: Lasers in Medical Science 4/2021

Open Access 01-06-2021 | Bronchoscopy | Original Article

Analysis of the short-term effect of photodynamic therapy on primary bronchial lung cancer

Authors: Cunzhi Lin, Yuanyuan Zhang, Qian Zhao, Pingping Sun, Zhe Gao, Shichao Cui

Published in: Lasers in Medical Science | Issue 4/2021

Login to get access

Abstract

To analyze the short-term clinical effect of photodynamic therapy on bronchial lung cancer and provide relevant practical experience for its better application in clinical practice. Twenty patients with bronchial lung cancer diagnosed by pathology were treated with photodynamic therapy or interventional tumor reduction combined with photodynamic therapy. Follow-up at 3 months after treatment, the chest CT and bronchoscopy were reexamined. The lesions were observed under a microscope, and the pathological specimens of living tissues were stained with HE and TUNEL to evaluate the short-term clinical effect. The volume of the tumor in the trachea or bronchus was smaller than before and the obstruction improved after the PDT from the chest CT. We could conclude that after PDT, the tumor volume was reduced and the pathological tissue appeared necrotic, the surface was pale, and the blood vessels were fewer while compared with before, and less likely to bleed when touched from the results of the bronchoscopy. HE staining showed that before treatment, there were a large number of tumor cells, closely arranged and disordered, or agglomerated and distributed unevenly. The cell morphology was not clear and the sizes were various with large and deeply stained nucleus, and the intercellular substance was less. After treatment, the number of tumor cells decreased significantly compared with before and the arrangement was relatively loose and orderly. The cells were roughly the same size; the intercellular substance increased obviously and showed uniform staining. The nuclei morphology was incomplete and fragmented, and tumor cells were evenly distributed among the intercellular substance. TUNEL staining showed that the number of cells was large and the nucleus morphology was regular before treatment; the nuclear membrane was clear and only a small number of apoptotic cells could be seen. However, the number of cells decreased and arranged loosely after treatment, with evenly stained cytoplasm. The nuclear morphology was irregular and the nuclear membrane cannot be seen clearly. Apoptotic cells with typical characteristics such as karyopyknosis, karyorrhexis, and karyolysis were common. Photodynamic therapy for bronchial lung cancer can achieve a satisfactory short-term clinical treatment effect and improve the life quality of patients, but the long-term clinical effect remains to be further studied.
Literature
1.
go back to reference Chen W, Zhang S, Zou X (2010) Evaluation on the incidence, mortality and tendency of lung cancer in China. Thorac Cancer 1(1):35–40CrossRef Chen W, Zhang S, Zou X (2010) Evaluation on the incidence, mortality and tendency of lung cancer in China. Thorac Cancer 1(1):35–40CrossRef
2.
go back to reference Dela Cruz CS, Tanoue LT, Matthay RA (2011) Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med 32(4):605–644CrossRef Dela Cruz CS, Tanoue LT, Matthay RA (2011) Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med 32(4):605–644CrossRef
3.
go back to reference Agostinis P et al (2011) Photodynamic therapy of cancer: an update. CA Cancer J Clin 61(4):250–281CrossRef Agostinis P et al (2011) Photodynamic therapy of cancer: an update. CA Cancer J Clin 61(4):250–281CrossRef
4.
go back to reference Leman JA, Morton CA (2002) Photodynamic therapy: applications in dermatology. Expert Opin Biol Ther 2(1):45–53CrossRef Leman JA, Morton CA (2002) Photodynamic therapy: applications in dermatology. Expert Opin Biol Ther 2(1):45–53CrossRef
5.
go back to reference Dougherty TJ et al (1978) Photoradiation therapy for the treatment of malignant tumors. Cancer Res 38(8):2628–2635PubMed Dougherty TJ et al (1978) Photoradiation therapy for the treatment of malignant tumors. Cancer Res 38(8):2628–2635PubMed
6.
go back to reference Huang Z (2008) An update on the regulatory status of Pdt photosensitizers in China. Photodiagnosis Photodyn Ther 5(4):285–287CrossRef Huang Z (2008) An update on the regulatory status of Pdt photosensitizers in China. Photodiagnosis Photodyn Ther 5(4):285–287CrossRef
7.
go back to reference McCaughan JS, Williams TE (1997) Photodynamic therapy for endobronchial malignant disease: a prospective fourteen-year study. J Thorac Cardiovasc Surg 114(6):940–947CrossRef McCaughan JS, Williams TE (1997) Photodynamic therapy for endobronchial malignant disease: a prospective fourteen-year study. J Thorac Cardiovasc Surg 114(6):940–947CrossRef
8.
go back to reference Moghissi K et al (1999) The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases. Eur J Cardiothorac Surg 15(1):1–6CrossRef Moghissi K et al (1999) The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases. Eur J Cardiothorac Surg 15(1):1–6CrossRef
9.
go back to reference Loewen GM et al (2006) Endobronchial photodynamic therapy for lung cancer. Lasers Surg Med 38(5):364–370CrossRef Loewen GM et al (2006) Endobronchial photodynamic therapy for lung cancer. Lasers Surg Med 38(5):364–370CrossRef
10.
go back to reference Jheon S, Kim T, Kim JK (2011) Photodynamic therapy as an adjunct to surgery or other treatments for squamous cell lung cancers. Laser Ther 20(2):107–116CrossRef Jheon S, Kim T, Kim JK (2011) Photodynamic therapy as an adjunct to surgery or other treatments for squamous cell lung cancers. Laser Ther 20(2):107–116CrossRef
11.
go back to reference Freitag L et al (2004) Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma. Thorax 59(9):790–793CrossRef Freitag L et al (2004) Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma. Thorax 59(9):790–793CrossRef
12.
go back to reference Corti L et al (2007) Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma. Lasers Surg Med 39(5):394–402CrossRef Corti L et al (2007) Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma. Lasers Surg Med 39(5):394–402CrossRef
13.
go back to reference Akopov A et al (2014) Preoperative endobronchial photodynamic therapy improves resectability in initially irresectable (inoperable) locally advanced non small cell lung cancer. Photodiagn Photodyn Ther 11(3):259–264CrossRef Akopov A et al (2014) Preoperative endobronchial photodynamic therapy improves resectability in initially irresectable (inoperable) locally advanced non small cell lung cancer. Photodiagn Photodyn Ther 11(3):259–264CrossRef
14.
go back to reference Zhang W et al (2016) Co-delivery of cisplatin prodrug and chlorin e6 by mesoporous silica nanoparticles for chemo-photodynamic combination therapy to combat drug resistance. ACS Appl Mater Interfaces 8(21):13332–13340CrossRef Zhang W et al (2016) Co-delivery of cisplatin prodrug and chlorin e6 by mesoporous silica nanoparticles for chemo-photodynamic combination therapy to combat drug resistance. ACS Appl Mater Interfaces 8(21):13332–13340CrossRef
15.
go back to reference Kimura M et al (2015) Photodynamic therapy (PDT) with chemotherapy for advanced lung cancer with airway stenosis. Int J Mol Sci 16(10):25466–25475CrossRef Kimura M et al (2015) Photodynamic therapy (PDT) with chemotherapy for advanced lung cancer with airway stenosis. Int J Mol Sci 16(10):25466–25475CrossRef
16.
go back to reference Gallagher-Colombo SM et al (2015) Erlotinib pretreatment improves photodynamic therapy of non-small cell lung carcinoma xenografts via multiple mechanisms. Cancer Res 75(15):3118–3126CrossRef Gallagher-Colombo SM et al (2015) Erlotinib pretreatment improves photodynamic therapy of non-small cell lung carcinoma xenografts via multiple mechanisms. Cancer Res 75(15):3118–3126CrossRef
17.
go back to reference Hopper C (2000) Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol 1(4):212–219CrossRef Hopper C (2000) Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol 1(4):212–219CrossRef
18.
go back to reference Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3(5):380–387CrossRef Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3(5):380–387CrossRef
19.
go back to reference Josefsen LB, Boyle RW (2012) Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics. Theranostics 2(9):916–966CrossRef Josefsen LB, Boyle RW (2012) Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics. Theranostics 2(9):916–966CrossRef
20.
go back to reference Nowak-Stepniowska A, Pergol P, Padzik-Graczyk A (2013) Photodynamic method of cancer diagnosis and therapy--mechanisms and applications. Postepy Biochem 59(1):53–63PubMed Nowak-Stepniowska A, Pergol P, Padzik-Graczyk A (2013) Photodynamic method of cancer diagnosis and therapy--mechanisms and applications. Postepy Biochem 59(1):53–63PubMed
21.
go back to reference Kessel D, Oleinick NL (2010) Photodynamic therapy and cell death pathways. Methods Mol Biol 635:35–46CrossRef Kessel D, Oleinick NL (2010) Photodynamic therapy and cell death pathways. Methods Mol Biol 635:35–46CrossRef
22.
go back to reference Mehraban N, Freemann HS (2015) Developments in PDT sensitizers for increased selectivity and singlet oxygen production. Materials (Basel) 8(7):4421–4456CrossRef Mehraban N, Freemann HS (2015) Developments in PDT sensitizers for increased selectivity and singlet oxygen production. Materials (Basel) 8(7):4421–4456CrossRef
23.
go back to reference Krammer B (2001) Vascular effects of photodynamic therapy. Anticancer Res 21(6b):4271–4277PubMed Krammer B (2001) Vascular effects of photodynamic therapy. Anticancer Res 21(6b):4271–4277PubMed
24.
go back to reference Huang Z et al (2008) Photodynamic therapy for treatment of solid tumors--potential and technical challenges. Technol Cancer Res Treat 7(4):309–320CrossRef Huang Z et al (2008) Photodynamic therapy for treatment of solid tumors--potential and technical challenges. Technol Cancer Res Treat 7(4):309–320CrossRef
25.
go back to reference Korbelik M (2006) PDT-associated host response and its role in the therapy outcome. Lasers Surg Med 38(5):500–508CrossRef Korbelik M (2006) PDT-associated host response and its role in the therapy outcome. Lasers Surg Med 38(5):500–508CrossRef
26.
go back to reference Kabingu E et al (2007) CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells. Br J Cancer 96(12):1839–1848CrossRef Kabingu E et al (2007) CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells. Br J Cancer 96(12):1839–1848CrossRef
27.
go back to reference Wang Y et al (2016) A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer. J Cancer Res Clin Oncol 142(4):813–821CrossRef Wang Y et al (2016) A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer. J Cancer Res Clin Oncol 142(4):813–821CrossRef
28.
go back to reference Reginato E, Wolf P, Hamblin MR (2014) Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects. World J Immunol 4(1):1–11CrossRef Reginato E, Wolf P, Hamblin MR (2014) Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects. World J Immunol 4(1):1–11CrossRef
29.
go back to reference Hwang HS et al (2018) Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy. J Pharm Investig 48(2):143–151CrossRef Hwang HS et al (2018) Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy. J Pharm Investig 48(2):143–151CrossRef
30.
go back to reference Xu P et al (2012) Receptor-targeting phthalocyanine photosensitizer for improving antitumor photocytotoxicity. PLoS One 7(5):e37051CrossRef Xu P et al (2012) Receptor-targeting phthalocyanine photosensitizer for improving antitumor photocytotoxicity. PLoS One 7(5):e37051CrossRef
31.
go back to reference Kwiatkowski S et al (2018) Photodynamic therapy-mechanisms, photosensitizers and combinations. Biomed Pharmacother 106(106):1098–1107CrossRef Kwiatkowski S et al (2018) Photodynamic therapy-mechanisms, photosensitizers and combinations. Biomed Pharmacother 106(106):1098–1107CrossRef
Metadata
Title
Analysis of the short-term effect of photodynamic therapy on primary bronchial lung cancer
Authors
Cunzhi Lin
Yuanyuan Zhang
Qian Zhao
Pingping Sun
Zhe Gao
Shichao Cui
Publication date
01-06-2021
Publisher
Springer London
Published in
Lasers in Medical Science / Issue 4/2021
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-020-03080-5

Other articles of this Issue 4/2021

Lasers in Medical Science 4/2021 Go to the issue